By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CytRx Corporation 

11726 San Vicente Blvd., Suite 650

Los Angeles  California  90049  U.S.A.
Phone: 310-826-5648 Fax: 310-826-6139


Company News
CytRx Corporation (CYTR) Reports 2015 Second Quarter Financial Results 8/3/2015 9:31:34 AM
CytRx Corporation (CYTR) Announces Closing Of Public Offering Of Common Stock, Including Full Exercise Of Underwriters' Option To Purchase Additional Shares 7/24/2015 9:46:26 AM
CytRx Corporation (CYTR) Announces Proposed Public Offering Of Common Stock 7/21/2015 11:03:59 AM
CytRx Corporation (CYTR) Announces Pricing Of Public Offering Of 9.1 Million Shares Of Common Stock 7/21/2015 9:15:59 AM
CytRx Corporation (CYTR) Unveils Novel LADR (Linker Activated Drug Release) Technology Platform 6/30/2015 7:20:27 AM
CytRx Corporation (CYTR) Announces Presentation Of Interim Phase 2 Data For Aldoxorubicin For HIV-Related Kaposi's Sarcoma 6/29/2015 9:45:53 AM
Cheryl Cohen, Former Medivation, Inc. (MDVN) Chief Commercial Officer, Joins CytRx Corporation (CYTR) Board Of Directors 6/24/2015 7:58:12 AM
CytRx Corporation (CYTR) Announces Settlement Of Stockholder Derivative Lawsuit In Delaware 6/2/2015 11:31:48 AM
CytRx Corporation (CYTR) To Present Aldoxorubicin Clinical Data At The 2015 ASCO Annual Meeting 5/27/2015 10:23:35 AM
CytRx Corporation (CYTR) To Present At The Jefferies and Co. 2015 Global Healthcare Conference 5/26/2015 10:11:46 AM